Tenofovir disoproxil fumarate (TDF) is effective against chronic hepatitis B (CHB) infection and its use is increasing rapidly worldwide. However, it has been established that TDF is associated with renal toxicity in human immunodeficiency virus-infected patients, while severe or symptomatic TDF-associated nephrotoxicity has rarely been reported in patients with CHB. Here we present two patients with TDF-associated nephrotoxicity who were being treated for CHB infection. The first patient was found to have clinical manifestations of proximal renal tubular dysfunction and histopathologic evidence of acute tubular necrosis at 5 months after starting TDF treatment. The second patient developed acute kidney injury at 17 days after commencing TDF, and he was found to have membranoproliferative glomerulonephritis with acute tubular injury. The renal function improved in both patients after discontinuing TDF. We discuss the risk factors for TDF-associated renal toxicity and present recommendations for monitoring renal function during TDF therapy.
Citations
Citations to this article as recorded by
Review Article: Renal Safety Profiles of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, and Entecavir for the Treatment of Chronic Hepatitis B Infection—General and Special Populations Lung‐Yi Mak, Tsung‐Hui Hu, Desmond Y. H. Yap Alimentary Pharmacology & Therapeutics.2026; 63(7): 945. CrossRef
Urinary Levels of Neutrophil Gelatinase-associated Lipocalin and Cystatin C in Patients with Hepatitis B on Tenofovir Treatment Shivani Rani, Himanshu Dandu, Ambuj Yadav, Mahak Lamba, Amit Goel, Wahid Ali, Virendra Atam, Sumit Rungta, Medhavi Gautam, Atin Singhai Journal of The Association of Physicians of India.2025; 73(2): 13. CrossRef
Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients David Sooik Kim, Soo Young Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang-Hyub Han, Yu Rim Lee, Won Young Tak, Young Oh Kweon, Inkyung Jung, Minkyung Han, Eun Hwa Kim, Sang Hoon Ahn, Seung Up Kim Journal of Korean Medical Science.2021;[Epub] CrossRef
Long-term Nucleotide Analogue Treatment Has Higher Levels of Renal Toxicities than Does Entecavir in Patients with Chronic Hepatitis B Young Youn Cho, Young Chang, Joon Yeul Nam, Hyeki Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim Gut and Liver.2020; 14(2): 225. CrossRef
Entecavir and tenofovir on renal function in patients with hepatitis B virus‐related hepatocellular carcinoma Mi Young Jeon, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang‐Hyub Han, Sang Hoon Ahn, Seung Up Kim Journal of Viral Hepatitis.2020; 27(9): 932. CrossRef
Editorial: tenofovir disoproxil fumarate vs entecavir in patients with chronic hepatitis B and renal impairment—still an open issue Sung Won Lee, Seung Up Kim Alimentary Pharmacology & Therapeutics.2020; 52(5): 889. CrossRef
Tenofovir does not induce renal dysfunction compared to entecavir in post-liver-transplant hepatitis B virus patients Sang Jin Kim, Jinsoo Rhu, Seo Hee Lee, Jong Man Kim, Gyu-Seong Choi, Kyunga Kim, Jae-Won Joh Annals of Surgical Treatment and Research.2020; 99(3): 180. CrossRef
A severe case of tenofovir-associated acute kidney injury requiring hemodialysis in a patient with chronic hepatitis B A Young Cho, Ju Hwan Oh, Hee-Chan Moon, Gum Mo Jung, Young Suk Lee, Yeong Jin Choi, In O Sun, Kwang Young Lee Kidney Research and Clinical Practice.2020; 39(3): 373. CrossRef
Renal Dysfunction and Tubulopathy Induced by High-Dose Tenofovir Disoproxil Fumarate in C57BL/6 Mice Eungyeong Jang, Jong Kil Lee, Kyung-Soo Inn, Eun Kyoung Chung, Kyung-Tae Lee, Jang-Hoon Lee Healthcare.2020; 8(4): 417. CrossRef
Application of High-Performance Liquid Chromatography for Simultaneous Determination of Tenofovir and Creatinine in Human Urine and Plasma Samples Patrycja Olejarz, Grażyna Chwatko, Paweł Kubalczyk, Krystian Purgat, Rafał Głowacki, Kamila Borowczyk Pharmaceuticals.2020; 13(11): 367. CrossRef
Tenofovir-Associated Acute Kidney Disease: Is it Different in HIV- and HBV-Infected Patients? Fatemeh Ghasemi, Mohammadreza Salehi, Niloofar Khoshnam Rad, Hossein Khalili American Journal of Therapeutics.2019; 26(5): e639. CrossRef
Tenofovir and Entecavir Have Similar Renal Adverse Events on Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization Young Youn Cho, Young Hwan Choi, Su Jong Yu, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon Journal of Liver Cancer.2019; 19(2): 128. CrossRef
Effect of tenofovir on renal function in patients with chronic hepatitis B Woo Jin Jung, Jae Young Jang, Won Young Park, Soung Won Jeong, Hee Jeong Lee, Sang Joon Park, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Suyeon Park, Baigal Baymbajav Medicine.2018; 97(7): e9756. CrossRef
Using the chronic kidney disease guidelines to evaluate the renal safety of tenofovir disoproxil fumarate in hepatitis B patients H. J. Tsai, Y. W. Chuang, S. W. Lee, C. Y. Wu, H. Z. Yeh, T. Y. Lee Alimentary Pharmacology & Therapeutics.2018; 47(12): 1673. CrossRef
First
Prev
